colorectal cancer, disease characterized by uncontrolled growth of cells within the large intestine (colon) or rectum (terminal portion of the large intestine). Colon cancer (or bowel cancer) and rectal cancer are sometimes referred to separately. Colorectal cancer develops slowly but can spread to surrounding and distant tissues of the body.
Causes and symptoms
Like most cancers, colorectal cancers have multiple causes, many of which remain unknown. Some cases appear to be inherited, while others seem to occur randomly or to have nongenetic causes. Approximately 95 percent of colorectal cancers involve the glandular cells in the wall of the colon and are called adenocarcinomas (see carcinoma). Other colorectal cancers may begin among hormone-producing cells, immune cells, or underlying connective tissue.
Several factors increase the risk of developing the disease. Colorectal cancer becomes more common with increasing age; 90 percent of cases are diagnosed in people 50 or more years old. A family history of colorectal cancer—specifically forms such as familial adenomatous polyposis (FAP), Gardner syndrome, and hereditary nonpolyposis colon cancer (HNPCC)—can predispose an individual to developing colorectal cancer. Each of these conditions is caused in part by a known genetic mutation. In addition, Ashkenazi Jews have a slightly higher incidence of colorectal cancer due to a mutated gene, and there exists a gene mutation that increases risk of colorectal cancer in people of European descent but does not increase risk in people of Japanese descent. This latter mutation, discovered in 2008, was the first to provide evidence of ethnic differences in genetic susceptibility to colorectal cancer.
Chronic inflammatory bowel diseases such as Crohn disease or ulcerative colitis are associated with colorectal cancer, as is the presence of a large number of noncancerous polyps along the wall of the colon or rectum. Other risk factors include physical inactivity and a diet high in fats. Those who have previously been treated for colorectal cancer are also at increased risk of recurrence. Certain gut bacteria, including species of Fusobacterium, have been implicated in colorectal cancer; Fusobacterium are present at increased levels in colorectal cancer patients and can trigger inflammatory responses associated with tumour growth and progression.
Because colorectal cancer is a disease of the digestive tract, many of the symptoms are associated with abnormal digestion and elimination. Symptoms include episodes of diarrhea or constipation that extend for days, blood in the stool, rectal bleeding, jaundice, abdominal pain, loss of appetite, and fatigue. Because these symptoms accompany a variety of different illnesses, a physician should be consulted to determine their cause.
Diagnoses of colon and rectal cancers are made by means of several techniques. During a digital rectal exam, the physician inserts a gloved finger into the rectum and feels its surface for abnormalities. A fecal test may also be used to detect the presence of blood in the stool. In order to examine the rectum more carefully, a physician may use a narrow, flexible tube called a sigmoidoscope to look at the lining of the rectum and the end of the colon. Colonoscopy uses a similar device to examine the entire colon. A biopsy may also be conducted in which abnormal tissue is removed by using the colonoscope and then examined under a microscope for signs of cancer. An X-ray procedure called a double-contrast barium enema may be used. Barium sulfate is used to coat the colon, and the colon is filled with air. A series of X rays are then taken, and the resulting high-contrast images indicate any abnormalities present.
If cancer is found, the degree to which it has spread (metastasized) from the colon or rectum is determined. Biopsies may be conducted of surrounding tissues, or one of several imaging techniques may be used to detect metastasis. Techniques include rectal ultrasound, magnetic resonance imaging (MRI), and X-ray or computed tomography (CT) scans.
Once colorectal cancer has been diagnosed, its stage is then determined to indicate how far the cancer has progressed. Stage 0 colorectal cancer is also called carcinoma in situ and is confined to the lining of the colon or rectum. Stage I cancers have spread into the connective tissue beneath the lining or into the underlying muscle layer. Stage II cancers have spread completely through the wall of the colon or rectum but have not invaded nearby lymph nodes. Stage III colorectal cancer has reached nearby lymph nodes, and stage IV cancers have spread to distant structures such as the lungs, liver, bones, or reproductive organs.
Colorectal cancer patients have an excellent five-year survival rate when the disease is detected early, and those who reach this stage often go on to live long, healthy lives. Approximately two-thirds of patients with local metastases survive for five or more years, but in cases where cancer is detected late and has spread to distant regions of the body, the five-year survival rate is very low.